首页 > 最新文献

Scottish Medical Journal最新文献

英文 中文
Editorial - Medical litigation in the 21st century. 社论- 21世纪的医疗诉讼。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-11-01 DOI: 10.1177/00369330211055810
Robyn Webber

The possibility of a medical negligence claim lies at the back of many doctors' minds. But which specialties see the greatest and fewest claims, and what are the potential costs to the NHS of a successful claim? In their article, Dr Lane et al. analyse 10 years' NHS litigation data, broken down by specialty, number of claims, and the attendant cost of those claims which were successful. Litigation in the 'post Montgomery' era is considered along with some of the common factors which may lead to a patient or their family taking legal action.

提出医疗过失索赔的可能性一直萦绕在许多医生的心头。但是,哪些专科的索赔最多,哪些索赔最少,成功索赔对NHS的潜在成本是什么?在他们的文章中,Lane博士等人分析了10年来NHS的诉讼数据,按专业、索赔数量和成功索赔的相关成本进行了细分。“后蒙哥马利”时代的诉讼与一些可能导致患者或其家属采取法律行动的常见因素一起被考虑。
{"title":"Editorial - Medical litigation in the 21st century.","authors":"Robyn Webber","doi":"10.1177/00369330211055810","DOIUrl":"https://doi.org/10.1177/00369330211055810","url":null,"abstract":"<p><p>The possibility of a medical negligence claim lies at the back of many doctors' minds. But which specialties see the greatest and fewest claims, and what are the potential costs to the NHS of a successful claim? In their article, Dr Lane et al. analyse 10 years' NHS litigation data, broken down by specialty, number of claims, and the attendant cost of those claims which were successful. Litigation in the 'post Montgomery' era is considered along with some of the common factors which may lead to a patient or their family taking legal action.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 4","pages":"166-167"},"PeriodicalIF":2.7,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39849686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Medicolegal issues in healthcare: Corporatisation of healthcare. 医疗保健中的医学法律问题:医疗保健的公司化。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-11-01 DOI: 10.1177/00369330211058808
Ghuam Nabi
A career in Medicine is often rewarding and profession is regarded as one of the noble professions. In a professional relationship between patient and doctor, due care is rendered based on principles of sincerity, trust and mutual understanding that outcome may not be predictable in certain circumstances and things can and will go wrong. however, axiom such as “you learn from your mistakes” is not considered as learning opportunity anymore and law is brought in by the patients to decide level of negligence by the doctors, in cases where perceived errors are witnessed. The judges with no knowledge of medical science decide degree of negligence and compensation based on medical expert opinions. In Cambridge dictionary, negligence is defined as “the fact of not giving enough care or attention to someone or something”. The parameters to categorise degree of negligence are often subjective and varied between; lata culpa, gross neglect; levis culpa’ ordinary neglect and levissima culpa, slight neglect (1). The decision on the level of negligence is further dependant on the context, circumstances of individuals and systems. In a medical error, it is often assumed that things have gone wrong and somebody needs to be punished and medical practitioners are often held responsible without observing any cautions that matters are invariably complex. The decisions to pursue cases of medicolegal negligence are often based on notions that what the best practice should have been rather than exhibiting deeper understanding of real-life practices. No distinction is made between a case of occupational negligence and professional negligence. A case of negligence should not be made on the basis that better alternatives or more skilled approach was likely to adopted in a case than the one under consideration. Rather Bolam test should be applied to the matters of negligence (2). The Bolam test is “The test is the standard of the ordinary skilled man exercising and professing to have that special skill” A practitioner is not negligent as long as he has acted in accordance with practice approved by a body of other responsible doctors. There is a less recognised side effect of negligence cases pursued by litigants against doctors. The impact of “fear of failure” by medical practitioners on society need to be realised and this may be counterproductive with potential for more harm than good. A dangling fear in the mind of surgeon of failure and subsequent prosecution would prevent him from acting in the best interest of patient. Similarly, a seriously sick patient with 10% chances of survival may not get resuscitated as failure to achieve a satisfactory outcome may land a medical practitioner into a court case and the fear may prevent him from acting in the best interest of patient. In contrast to spending resources on pursuing matters of perceived negligence by society, we should be spending on prevention. Use of apology, clinical guidelines and proper documentation are some
{"title":"Medicolegal issues in healthcare: Corporatisation of healthcare.","authors":"Ghuam Nabi","doi":"10.1177/00369330211058808","DOIUrl":"https://doi.org/10.1177/00369330211058808","url":null,"abstract":"A career in Medicine is often rewarding and profession is regarded as one of the noble professions. In a professional relationship between patient and doctor, due care is rendered based on principles of sincerity, trust and mutual understanding that outcome may not be predictable in certain circumstances and things can and will go wrong. however, axiom such as “you learn from your mistakes” is not considered as learning opportunity anymore and law is brought in by the patients to decide level of negligence by the doctors, in cases where perceived errors are witnessed. The judges with no knowledge of medical science decide degree of negligence and compensation based on medical expert opinions. In Cambridge dictionary, negligence is defined as “the fact of not giving enough care or attention to someone or something”. The parameters to categorise degree of negligence are often subjective and varied between; lata culpa, gross neglect; levis culpa’ ordinary neglect and levissima culpa, slight neglect (1). The decision on the level of negligence is further dependant on the context, circumstances of individuals and systems. In a medical error, it is often assumed that things have gone wrong and somebody needs to be punished and medical practitioners are often held responsible without observing any cautions that matters are invariably complex. The decisions to pursue cases of medicolegal negligence are often based on notions that what the best practice should have been rather than exhibiting deeper understanding of real-life practices. No distinction is made between a case of occupational negligence and professional negligence. A case of negligence should not be made on the basis that better alternatives or more skilled approach was likely to adopted in a case than the one under consideration. Rather Bolam test should be applied to the matters of negligence (2). The Bolam test is “The test is the standard of the ordinary skilled man exercising and professing to have that special skill” A practitioner is not negligent as long as he has acted in accordance with practice approved by a body of other responsible doctors. There is a less recognised side effect of negligence cases pursued by litigants against doctors. The impact of “fear of failure” by medical practitioners on society need to be realised and this may be counterproductive with potential for more harm than good. A dangling fear in the mind of surgeon of failure and subsequent prosecution would prevent him from acting in the best interest of patient. Similarly, a seriously sick patient with 10% chances of survival may not get resuscitated as failure to achieve a satisfactory outcome may land a medical practitioner into a court case and the fear may prevent him from acting in the best interest of patient. In contrast to spending resources on pursuing matters of perceived negligence by society, we should be spending on prevention. Use of apology, clinical guidelines and proper documentation are some","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 4","pages":"165"},"PeriodicalIF":2.7,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39849692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation and management of papillary thyroid microcarcinoma - a Scottish regional case series and literature review. 甲状腺乳头状微癌的调查和治疗-苏格兰地区病例系列和文献综述。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-11-01 Epub Date: 2021-07-26 DOI: 10.1177/00369330211032352
Timothy Davies, William Royce, Robin Crosbie, Richard Townsley

Background and aims: Papillary thyroid microcarcinoma is defined as papillary thyroid cancer with a diameter of ≤1 cm. Despite its prevalence, there is wide variation in practice in the investigation and management of patients with papillary thyroid microcarcinoma throughout the UK and internationally. The primary aim of this paper is to describe the experience of investigation and management in a Scottish health board over the past 10 years.

Methods and results: Retrospective analysis of thyroidectomy and hemithyroidectomy resection samples from March 2009 to March 2020. 532 specimens were reviewed and 20 patients with PTMC were identified. 12 patients had an incidental finding of PTMC. Median U score- 3, Median Thy score- 2.5 for dominant or radiologically suspicious nodules. 8 specimens demonstrated aggressive histopathological features. 1 patient with positive nodal disease in the neck and 0 patients with positive nodal disease in the thorax on CT Neck and Chest.

Conclusion: Here we report the first UK Cohort describing the radiological investigation and management of papillary thyroid microcarcinoma. The results of our study are in accordance with a recent meta-analysis which found 4% nodal disease and 0.025% distant metastasis at time of presentation in patients with PTMC.

背景与目的:甲状腺乳头状微癌定义为直径≤1cm的甲状腺乳头状癌。尽管它很流行,但在英国和国际上对甲状腺乳头状微癌患者的调查和管理实践中存在很大差异。本文的主要目的是描述在过去10年的调查和管理在苏格兰卫生委员会的经验。方法与结果:回顾性分析2009年3月至2020年3月甲状腺、甲状腺切除术标本。我们对532例标本进行了回顾,并确定了20例PTMC患者。12例患者偶然发现PTMC。显性结节或放射学上可疑结节的中位U评分- 3,中位Thy评分- 2.5。8例呈侵袭性组织病理学特征。颈部及胸部CT淋巴结病变阳性1例,胸部淋巴结病变阳性0例。结论:在这里,我们报告了英国第一个队列,描述了甲状腺乳头状微癌的放射学调查和治疗。我们的研究结果与最近的一项荟萃分析一致,该分析发现PTMC患者在出现时有4%的淋巴结疾病和0.025%的远处转移。
{"title":"Investigation and management of papillary thyroid microcarcinoma - a Scottish regional case series and literature review.","authors":"Timothy Davies,&nbsp;William Royce,&nbsp;Robin Crosbie,&nbsp;Richard Townsley","doi":"10.1177/00369330211032352","DOIUrl":"https://doi.org/10.1177/00369330211032352","url":null,"abstract":"<p><strong>Background and aims: </strong>Papillary thyroid microcarcinoma is defined as papillary thyroid cancer with a diameter of ≤1 cm. Despite its prevalence, there is wide variation in practice in the investigation and management of patients with papillary thyroid microcarcinoma throughout the UK and internationally. The primary aim of this paper is to describe the experience of investigation and management in a Scottish health board over the past 10 years.</p><p><strong>Methods and results: </strong>Retrospective analysis of thyroidectomy and hemithyroidectomy resection samples from March 2009 to March 2020. 532 specimens were reviewed and 20 patients with PTMC were identified. 12 patients had an incidental finding of PTMC. Median U score- 3, Median Thy score- 2.5 for dominant or radiologically suspicious nodules. 8 specimens demonstrated aggressive histopathological features. 1 patient with positive nodal disease in the neck and 0 patients with positive nodal disease in the thorax on CT Neck and Chest.</p><p><strong>Conclusion: </strong>Here we report the first UK Cohort describing the radiological investigation and management of papillary thyroid microcarcinoma. The results of our study are in accordance with a recent meta-analysis which found 4% nodal disease and 0.025% distant metastasis at time of presentation in patients with PTMC.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 4","pages":"191-196"},"PeriodicalIF":2.7,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/00369330211032352","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39218736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Image guided ablation. 图像引导消融。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-11-01 DOI: 10.1177/0036933020973637
Xinrui Zhang, Andreas Melzer
Ablation refers to the local application of optical, acoustic or electrical energy and cold as to induce irreversible cell injury, apoptosis and coagulative necrosis of tissues. By contrast to surgical excision, ablation is a minimally invasive treatment option, whereby the scarified tissue remains in situ and is being absorbed over several months and transformed to a scar. Clinical use of ablation encompasses the treatment of various tumors, including liver, lung, kidney, pancreatic, head and neck cancer and bone metastasis. Additionally, neurological disorders, particularly essential tremor and Parkinson’s disease, can be treated by ablation of brain tissue or neuronal structures. Relatively novel is the use electrical energy in a certain pattern that induces cell apoptosis without coagulation, referred to irreversible electroporation (IRE), see Rui Chen et al. in this issue of SMJ. In order to decide which kind of local cell destruction is useful and can be applied safely a thorough understanding of the underlying principles is essential. In addition, it is required to use an appropriate imaging technology to monitor and control the process of tissue destruction. The process of energy-induced cell/tissue destruction consists of two phases through direct and indirect mechanisms. The direct damage of cells occurs rapidly after exposure of the target tissue to high temperature, alteration of the cell membrane, dysfunction of mitochondrial and inhibition of DNA replication. Changes of cell membrane fluidity and permeability are considered as the major cause of cell injury, leading to dysfunction of actin filaments and microtubules and impairment of facilitated diffusion across the cell membrane. Mitochondria are affected by high temperature, increasing leakage of protons through the inner mitochondrial membrane and changing the ultrastructure in minutes. Besides the changes in cellular level, heatinduced denaturation of key replication enzymes DNA polymerase a and b, which is responsible for semiconservative DNA replication and DNA repair synthesis respectively, thereby inhibiting DNA replication. Denaturation of polymerase substrate chromatin, abnormal condensation of non-histone nuclear matrix proteins, disruption of RNA synthesis and the release of lysosomal enzymes are believed the mechanisms of heat-mediated reproductive cell death. The indirect mechanism occurs via several mechanisms, including induction of apoptosis, the release of cytokines and stimulation of immune response. Apoptosis is increased in the peripheral zone of the central ablated lesion, which undergoes coagulative necrosis. Expression of essential apoptotic protein p53 was upregulated and bcl-2 was downregulated in human liver cancer tissues after ablation treatment. Release of pro-inflammatory cytokines such as interleukin-1b (IL-1b), IL-6, IL-8, IL-18 and tumor necrosis factor-a (TNF-a) increase in several hours to days after ablation maximize the anti-tumor response. Heat
{"title":"Image guided ablation.","authors":"Xinrui Zhang,&nbsp;Andreas Melzer","doi":"10.1177/0036933020973637","DOIUrl":"https://doi.org/10.1177/0036933020973637","url":null,"abstract":"Ablation refers to the local application of optical, acoustic or electrical energy and cold as to induce irreversible cell injury, apoptosis and coagulative necrosis of tissues. By contrast to surgical excision, ablation is a minimally invasive treatment option, whereby the scarified tissue remains in situ and is being absorbed over several months and transformed to a scar. Clinical use of ablation encompasses the treatment of various tumors, including liver, lung, kidney, pancreatic, head and neck cancer and bone metastasis. Additionally, neurological disorders, particularly essential tremor and Parkinson’s disease, can be treated by ablation of brain tissue or neuronal structures. Relatively novel is the use electrical energy in a certain pattern that induces cell apoptosis without coagulation, referred to irreversible electroporation (IRE), see Rui Chen et al. in this issue of SMJ. In order to decide which kind of local cell destruction is useful and can be applied safely a thorough understanding of the underlying principles is essential. In addition, it is required to use an appropriate imaging technology to monitor and control the process of tissue destruction. The process of energy-induced cell/tissue destruction consists of two phases through direct and indirect mechanisms. The direct damage of cells occurs rapidly after exposure of the target tissue to high temperature, alteration of the cell membrane, dysfunction of mitochondrial and inhibition of DNA replication. Changes of cell membrane fluidity and permeability are considered as the major cause of cell injury, leading to dysfunction of actin filaments and microtubules and impairment of facilitated diffusion across the cell membrane. Mitochondria are affected by high temperature, increasing leakage of protons through the inner mitochondrial membrane and changing the ultrastructure in minutes. Besides the changes in cellular level, heatinduced denaturation of key replication enzymes DNA polymerase a and b, which is responsible for semiconservative DNA replication and DNA repair synthesis respectively, thereby inhibiting DNA replication. Denaturation of polymerase substrate chromatin, abnormal condensation of non-histone nuclear matrix proteins, disruption of RNA synthesis and the release of lysosomal enzymes are believed the mechanisms of heat-mediated reproductive cell death. The indirect mechanism occurs via several mechanisms, including induction of apoptosis, the release of cytokines and stimulation of immune response. Apoptosis is increased in the peripheral zone of the central ablated lesion, which undergoes coagulative necrosis. Expression of essential apoptotic protein p53 was upregulated and bcl-2 was downregulated in human liver cancer tissues after ablation treatment. Release of pro-inflammatory cytokines such as interleukin-1b (IL-1b), IL-6, IL-8, IL-18 and tumor necrosis factor-a (TNF-a) increase in several hours to days after ablation maximize the anti-tumor response. Heat","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 4","pages":"175-177"},"PeriodicalIF":2.7,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/e3/10.1177_0036933020973637.PMC8573691.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39849690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality. 胸部x线评分作为COVID-19疾病的预测因子与合并症和住院死亡率的相关性。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 Epub Date: 2021-06-26 DOI: 10.1177/00369330211027447
Aparajita Singh, Yoke Hong Lim, Rajesh Annamalaisamy, Shyam Sunder Koteyar, Suresh Chandran, Avinash Kumar Kanodia, Navin Khanna

Objectives: To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality.

Methods: We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid & lower and left, upper mid & lower zones). We scored each zone as- 0, 1 or 2 as follows- if that zone was clear (0) Ground glass opacity (1) or Consolidation (2). A total of score from 0 to 12 could be obtained.

Results: A CXR score cut off ≥3 independently predicted mortality. Along with a relatively higher NPV ≥80%, it reinforced the importance of CXR score is a screening tool to triage patients according to risk of mortality.

Conclusions: We propose that Pennine score is a simple tool which can be adapted by various countries, experiencing a large surge in number of patients, to decide which patient would need a tertiary Hospital referral/admission as opposed to patients that can be managed locally or at basic/primary care hospitals.

目的:设计一种新颖、简单的胸部x线(CXR)评分系统,有助于预测疾病的严重程度,预测合并症和住院死亡率。方法:本研究共纳入343例连续住院的COVID-19患者。这些患者的胸部x光片由三位独立的放射科医生回顾性评分。我们将CXR划分为六个区域(右上、中、下和左上、中、下区域)。我们给每个区域打分为- 0,1或2,如下所示-如果该区域清晰(0),则毛玻璃不透明(1)或固结(2)。总分从0到12可以得到。结果:CXR评分≥3分可独立预测死亡率。随着NPV≥80%的相对较高,它加强了CXR评分作为根据死亡风险对患者进行分类的筛查工具的重要性。结论:我们建议,Pennine评分是一种简单的工具,可以适用于患者数量激增的各个国家,以决定哪些患者需要三级医院转诊/入院,而不是可以在当地或在基础/初级保健医院进行管理的患者。
{"title":"Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","authors":"Aparajita Singh,&nbsp;Yoke Hong Lim,&nbsp;Rajesh Annamalaisamy,&nbsp;Shyam Sunder Koteyar,&nbsp;Suresh Chandran,&nbsp;Avinash Kumar Kanodia,&nbsp;Navin Khanna","doi":"10.1177/00369330211027447","DOIUrl":"https://doi.org/10.1177/00369330211027447","url":null,"abstract":"<p><strong>Objectives: </strong>To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality.</p><p><strong>Methods: </strong>We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid & lower and left, upper mid & lower zones). We scored each zone as- 0, 1 or 2 as follows- if that zone was clear (0) Ground glass opacity (1) or Consolidation (2). A total of score from 0 to 12 could be obtained.</p><p><strong>Results: </strong>A CXR score cut off ≥3 independently predicted mortality. Along with a relatively higher NPV ≥80%, it reinforced the importance of CXR score is a screening tool to triage patients according to risk of mortality.</p><p><strong>Conclusions: </strong>We propose that Pennine score is a simple tool which can be adapted by various countries, experiencing a large surge in number of patients, to decide which patient would need a tertiary Hospital referral/admission as opposed to patients that can be managed locally or at basic/primary care hospitals.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"101-107"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/00369330211027447","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39112404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
One-year real life data of our patients with moderate-severe Crohn's disease who underwent ustekinumab therapy. 接受ustekinumab治疗的中重度克罗恩病患者一年的真实生活数据。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 Epub Date: 2021-04-09 DOI: 10.1177/00369330211008587
Ferhat Bacaksız, Derya Arı, Volkan Gökbulut, Ömer Öztürk, Ertuğrul Kayaçetin

Aim: The aim of this study was to present one-year real-life data of our patients with CD who showed unresponsiveness and/or intolerance to biological agents and then received ustekinumab treatment through an early access program.

Materials and methods: The retrospective study reviewed the 52-week clinical data of 10 patients with moderate or severe CD who underwent ustekinumab therapy.

Results: The 10 patients comprised 7 (70%) men and 3 (30%) women with a mean age of 38 ± 11.3 years. Mean disease duration was 13.5 ± 8.5 years. Mean pretreatment CDAI score was 273.5 ± 92 and mean pretreatment HBI score was 11.6 ± 3.8. At the end of the 8-week intravenous induction treatment, 5 (55%) patients showed clinical remission according to the CDAI and HBI scores. Additionally, 62.5% of the patients were in clinical remission at the end of week 52 according to the CDAI and HBI scores. No drug-related side effects were observed in any patient throughout the treatment.

Conclusion: Ustekinumab appears to be effective and safe in the treatment of moderate and severe CD, particularly in cases of unresponsiveness and intolerance to biological agents such as anti-TNF, and in the achievement of clinical remission.

目的:本研究的目的是提供我们的乳糜泻患者一年的真实数据,这些患者对生物药物无反应和/或不耐受,然后通过早期获取计划接受了ustekinumab治疗。材料和方法:回顾性研究回顾了10例接受ustekinumab治疗的中重度CD患者的52周临床资料。结果:10例患者中男性7例(70%),女性3例(30%),平均年龄38±11.3岁。平均病程13.5±8.5年。预处理平均CDAI评分为273.5±92分,预处理平均HBI评分为11.6±3.8分。8周静脉诱导治疗结束时,根据CDAI和HBI评分,5例(55%)患者出现临床缓解。此外,根据CDAI和HBI评分,62.5%的患者在第52周末达到临床缓解。在整个治疗过程中,没有观察到任何患者的药物相关副作用。结论:Ustekinumab在治疗中度和重度CD方面似乎是有效和安全的,特别是在对抗tnf等生物制剂无反应和不耐受的情况下,以及在实现临床缓解方面。
{"title":"One-year real life data of our patients with moderate-severe Crohn's disease who underwent ustekinumab therapy.","authors":"Ferhat Bacaksız,&nbsp;Derya Arı,&nbsp;Volkan Gökbulut,&nbsp;Ömer Öztürk,&nbsp;Ertuğrul Kayaçetin","doi":"10.1177/00369330211008587","DOIUrl":"https://doi.org/10.1177/00369330211008587","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to present one-year real-life data of our patients with CD who showed unresponsiveness and/or intolerance to biological agents and then received ustekinumab treatment through an early access program.</p><p><strong>Materials and methods: </strong>The retrospective study reviewed the 52-week clinical data of 10 patients with moderate or severe CD who underwent ustekinumab therapy.</p><p><strong>Results: </strong>The 10 patients comprised 7 (70%) men and 3 (30%) women with a mean age of 38 ± 11.3 years. Mean disease duration was 13.5 ± 8.5 years. Mean pretreatment CDAI score was 273.5 ± 92 and mean pretreatment HBI score was 11.6 ± 3.8. At the end of the 8-week intravenous induction treatment, 5 (55%) patients showed clinical remission according to the CDAI and HBI scores. Additionally, 62.5% of the patients were in clinical remission at the end of week 52 according to the CDAI and HBI scores. No drug-related side effects were observed in any patient throughout the treatment.</p><p><strong>Conclusion: </strong>Ustekinumab appears to be effective and safe in the treatment of moderate and severe CD, particularly in cases of unresponsiveness and intolerance to biological agents such as anti-TNF, and in the achievement of clinical remission.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"152-157"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/00369330211008587","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25582523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Scottish Cardiac Society. 苏格兰心脏协会。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 DOI: 10.1177/0036933020986069
Scottish Cardiac Society Post myocardial infarction VSD closure: experience from Edinburgh Royal Infirmary Jack PM Andrews, David Northridge and Miles WH Behan Cardiology Registrar, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK Consultant Cardiologist, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK Abstract Introduction: Post myocardial infarction ventricular septal defect (PMIVSD) is a devastating complication with an in hospital mortality of 42%. Surgical and percutaneous repair are the current treatment options. Here, we describe our experience of post MI VSD repair in the Royal infirmary of Edinburgh from May 2015 to July 2019. Methods: Data was collected from electronic case records. Baseline demographics, mode of presentation, VSD location, size and occluder device type were recorded. Major comorbidity and mortality at one year were recorded where possible. Results: 13 post MI VSD repairs were performed within the timeframe. Mean age at presentation was 70 11 years. 4 were from NHS Lothian, 8 from elsewhere in Scotland and one overseas patient. 7 were female. 8 presented with acute inferior STEMI, 3 anterior STEMI and two without ST elevation on the ECG. VSD location was inferior in 10 and anterior in 3. 9 were initially treated with percutaneous closure, 2 of which went on to have surgical revision. Of the 4 initially repaired surgically, 2 went on to have further percutaneous closure. 10 patients survived to discharge with 3 in hospital deaths (23% in hospital mortality). One year survival was 46% (6/13). Conclusions: In the era of primary PCI, post-infarction VSD is now a rare complication. Our in-hospital mortality rate of 23% suggests that the outlook for these patients may have improved, slightly, compared to historical series. Initial treatment choice between surgical or percutaneous repair requires multi-disciplinary team discussion and is based on clinical stability, operative risk and VSD morphology, and a significant proportion of cases (4 out of 13 in our series) will require both approaches. ReferenceIntroduction: Post myocardial infarction ventricular septal defect (PMIVSD) is a devastating complication with an in hospital mortality of 42%. Surgical and percutaneous repair are the current treatment options. Here, we describe our experience of post MI VSD repair in the Royal infirmary of Edinburgh from May 2015 to July 2019. Methods: Data was collected from electronic case records. Baseline demographics, mode of presentation, VSD location, size and occluder device type were recorded. Major comorbidity and mortality at one year were recorded where possible. Results: 13 post MI VSD repairs were performed within the timeframe. Mean age at presentation was 70 11 years. 4 were from NHS Lothian, 8 from elsewhere in Scotland and one overseas patient. 7 were female. 8 presented with acute inferior STEMI, 3 anterior STEMI and two without ST elevation on the ECG. VSD location was inferior in 10
{"title":"Scottish Cardiac Society.","authors":"","doi":"10.1177/0036933020986069","DOIUrl":"https://doi.org/10.1177/0036933020986069","url":null,"abstract":"Scottish Cardiac Society Post myocardial infarction VSD closure: experience from Edinburgh Royal Infirmary Jack PM Andrews, David Northridge and Miles WH Behan Cardiology Registrar, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK Consultant Cardiologist, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK Abstract Introduction: Post myocardial infarction ventricular septal defect (PMIVSD) is a devastating complication with an in hospital mortality of 42%. Surgical and percutaneous repair are the current treatment options. Here, we describe our experience of post MI VSD repair in the Royal infirmary of Edinburgh from May 2015 to July 2019. Methods: Data was collected from electronic case records. Baseline demographics, mode of presentation, VSD location, size and occluder device type were recorded. Major comorbidity and mortality at one year were recorded where possible. Results: 13 post MI VSD repairs were performed within the timeframe. Mean age at presentation was 70 11 years. 4 were from NHS Lothian, 8 from elsewhere in Scotland and one overseas patient. 7 were female. 8 presented with acute inferior STEMI, 3 anterior STEMI and two without ST elevation on the ECG. VSD location was inferior in 10 and anterior in 3. 9 were initially treated with percutaneous closure, 2 of which went on to have surgical revision. Of the 4 initially repaired surgically, 2 went on to have further percutaneous closure. 10 patients survived to discharge with 3 in hospital deaths (23% in hospital mortality). One year survival was 46% (6/13). Conclusions: In the era of primary PCI, post-infarction VSD is now a rare complication. Our in-hospital mortality rate of 23% suggests that the outlook for these patients may have improved, slightly, compared to historical series. Initial treatment choice between surgical or percutaneous repair requires multi-disciplinary team discussion and is based on clinical stability, operative risk and VSD morphology, and a significant proportion of cases (4 out of 13 in our series) will require both approaches. ReferenceIntroduction: Post myocardial infarction ventricular septal defect (PMIVSD) is a devastating complication with an in hospital mortality of 42%. Surgical and percutaneous repair are the current treatment options. Here, we describe our experience of post MI VSD repair in the Royal infirmary of Edinburgh from May 2015 to July 2019. Methods: Data was collected from electronic case records. Baseline demographics, mode of presentation, VSD location, size and occluder device type were recorded. Major comorbidity and mortality at one year were recorded where possible. Results: 13 post MI VSD repairs were performed within the timeframe. Mean age at presentation was 70 11 years. 4 were from NHS Lothian, 8 from elsewhere in Scotland and one overseas patient. 7 were female. 8 presented with acute inferior STEMI, 3 anterior STEMI and two without ST elevation on the ECG. VSD location was inferior in 10 ","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"NP15-NP29"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/0036933020986069","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39259211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography measurements in patients with systemic hypertension. 全身性高血压患者的光学相干断层扫描测量。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 Epub Date: 2021-05-04 DOI: 10.1177/00369330211011175
Özlem Bursali, Özgül Altintaş, Ayşen Ağir, Nurşen Yüksel, Berna Özkan

Aim: To evaluate the effect of systemic arterial hypertension (SAH) on retinal optical coherence tomography (OCT) parameters and investigate whether a correlation exists between ambulatory blood pressure monitoring (ABPM) and OCT measurements.Material-methods: 115 SAH patients (225 eyes) and 123 healthy control cases (234 eyes) were included. ABPM was performed on 89 of 115 SAH patients. All patients underwent detailed ophthalmologic examination including imaging with OCT. SAH patients were divided into two groups (dippers, non-dippers) according to their nocturnal blood pressure (BP) reduction, and OCT measurements were compared.

Results: Average and superior retinal nerve fiber layer (RNFL) quadrants were significantly thin in hypertensive cases (p:0.002, p < 0.001, respectively). Cup area, cup/disk (c/d) area, and c/d horizontal ratios were wider; the rim area was smaller in hypertensive cases (respectively: p:0.024, p:0.017, p:0.003, p < 0.001). Total macular volume (TMV), the thicknesses in 1-3 and 1-6 mm of the macula were less in hypertensives (p < 0.001). There was no significant difference between dippers and non-dippers in RNFL thickness, macula and optic nerve head (ONH) parameters.

Conclusion: There were statistically significant differences between healthy cases and patients with SAH in terms of RNFL, macula thicknesses and ONH parameters.

目的:评价全身性动脉高血压(SAH)对视网膜光学相干断层扫描(OCT)参数的影响,探讨动态血压监测(ABPM)与OCT测量是否存在相关性。材料方法:纳入SAH患者115例(225眼)和健康对照123例(234眼)。115例SAH患者中89例行ABPM。所有患者均接受了详细的眼科检查,包括OCT成像。根据夜间血压(BP)下降情况,将SAH患者分为两组(俯卧者和非俯卧者),并比较OCT测量值。结果:高血压患者视网膜上神经纤维层(RNFL)平均象限和上象限明显变薄(p:0.002, p)。结论:健康患者与SAH患者在RNFL、黄斑厚度和ONH参数方面差异有统计学意义。
{"title":"Optical coherence tomography measurements in patients with systemic hypertension.","authors":"Özlem Bursali,&nbsp;Özgül Altintaş,&nbsp;Ayşen Ağir,&nbsp;Nurşen Yüksel,&nbsp;Berna Özkan","doi":"10.1177/00369330211011175","DOIUrl":"https://doi.org/10.1177/00369330211011175","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the effect of systemic arterial hypertension (SAH) on retinal optical coherence tomography (OCT) parameters and investigate whether a correlation exists between ambulatory blood pressure monitoring (ABPM) and OCT measurements.Material-methods: 115 SAH patients (225 eyes) and 123 healthy control cases (234 eyes) were included. ABPM was performed on 89 of 115 SAH patients. All patients underwent detailed ophthalmologic examination including imaging with OCT. SAH patients were divided into two groups (dippers, non-dippers) according to their nocturnal blood pressure (BP) reduction, and OCT measurements were compared.</p><p><strong>Results: </strong>Average and superior retinal nerve fiber layer (RNFL) quadrants were significantly thin in hypertensive cases (p:0.002, p < 0.001, respectively). Cup area, cup/disk (c/d) area, and c/d horizontal ratios were wider; the rim area was smaller in hypertensive cases (respectively: p:0.024, p:0.017, p:0.003, p < 0.001). Total macular volume (TMV), the thicknesses in 1-3 and 1-6 mm of the macula were less in hypertensives (p < 0.001). There was no significant difference between dippers and non-dippers in RNFL thickness, macula and optic nerve head (ONH) parameters.</p><p><strong>Conclusion: </strong>There were statistically significant differences between healthy cases and patients with SAH in terms of RNFL, macula thicknesses and ONH parameters.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"115-121"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/00369330211011175","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38949326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Squamous-cell carcinoma due to mesh infection after umbilical hernia operation: third case of the literature. 脐疝术后网状物感染致鳞状细胞癌:文献第三例。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 Epub Date: 2021-06-24 DOI: 10.1177/00369330211027465
Mehmet Esat Duymus, Ozlem Ipci

Introduction: Polypropylene (PP) meshes are safe synthetic products used for hernia repairs and associated with minimal complication. Chronic inflammation is thought to play a pathophysiological role in the development of cancer.Case presentation: We present a 67-year-old female case of squamous cell-cancer (SCC) that developed due to mesh after umbilical hernia operation. The mass in the anterior abdominal wall was totally resected. Pathology was reported as T2N0, moderately differentiated acantholytic type SCC. No recurrence or complication was detected in the fourth-month follow-up.

Conclusion: Cancer development after mesh is very rare and our case is the third case in the literature. Cancer development should be kept in mind in patients presenting with ulcerated masses if do not regress with infection treatment after mesh application.

简介:聚丙烯(PP)网是一种安全的合成产品,用于疝修补,并发症最小。慢性炎症被认为在癌症的发展中起着病理生理作用。病例报告:我们报告一位67岁的女性,因脐疝手术后补片而发展为鳞状细胞癌(SCC)。前腹壁肿块完全切除。病理报告为T2N0,中分化棘层溶解型SCC。随访4个月无复发及并发症发生。结论:补片术后肿瘤发展非常罕见,本病例为文献中第三例。如果在补片应用后感染治疗不消退,出现溃疡肿块的患者应注意癌症的发展。
{"title":"Squamous-cell carcinoma due to mesh infection after umbilical hernia operation: third case of the literature.","authors":"Mehmet Esat Duymus,&nbsp;Ozlem Ipci","doi":"10.1177/00369330211027465","DOIUrl":"https://doi.org/10.1177/00369330211027465","url":null,"abstract":"<p><strong>Introduction: </strong>Polypropylene (PP) meshes are safe synthetic products used for hernia repairs and associated with minimal complication. Chronic inflammation is thought to play a pathophysiological role in the development of cancer.<b>Case presentation:</b> We present a 67-year-old female case of squamous cell-cancer (SCC) that developed due to mesh after umbilical hernia operation. The mass in the anterior abdominal wall was totally resected. Pathology was reported as T2N0, moderately differentiated acantholytic type SCC. No recurrence or complication was detected in the fourth-month follow-up.</p><p><strong>Conclusion: </strong>Cancer development after mesh is very rare and our case is the third case in the literature. Cancer development should be kept in mind in patients presenting with ulcerated masses if do not regress with infection treatment after mesh application.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"158-161"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/00369330211027465","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39101013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Introduction of paediatric laparoscopic cholecystectomy in Scotland: a national review of incidence, outcomes and training implications. 介绍儿科腹腔镜胆囊切除术在苏格兰:发病率,结果和培训意义的国家审查。
IF 2.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2021-08-01 Epub Date: 2021-03-27 DOI: 10.1177/0036933021995958
P Sekaran, A R Ross, A Rooney, G Duthie, M Clarke, F D Munro, A J Sabharwal

Background: We present a national data series to determine the incidence, outcomes and training opportunities for laparoscopic cholecystectomy among children <16yrs in Scotland as performed by paediatric surgeons.

Methods: A retrospective cohort study was performed reviewing laparoscopic cholecystectomy performed at the three children's hospitals in Scotland. Using the National Records Scotland Database mid-year population estimates; age and sex specific annual incidence rates of laparoscopic cholecystectomy were calculated between 1998-2015. Trends in the observed case mix were tested using univariate linear regression and students t-test.

Results: Between 1998-2015; 141 paediatric laparoscopic cholecystectomies were performed. The annual rate of cholecystectomy increased from 0.10/100,000 to 0.88/100,000 (p = 0.069). Sex specific incidences were identified; 0.00-0.90/100,000 (p = 0.098) in girls and 0.20-0.86/100,000 in boys (p = 0.28). Cholecystectomy was more frequent in girls (63%; p = 0.04). No major complications, defined as common bile duct injury or mortality were identified. Overall; 75% of cases were performed by consultants (n = 17 consultants, median = 5 cases, p < 0.05) and 25% by trainees.

Conclusion: We have demonstrated that despite a low national case load (8 laparoscopic cholecystectomies per year) paediatric surgeons have been able to perform laparoscopic cholecystectomy safely without major morbidity.

背景:我们提出了一个全国性的数据系列,以确定儿童腹腔镜胆囊切除术的发生率、结局和培训机会。方法:进行了一项回顾性队列研究,回顾了苏格兰三家儿童医院进行的腹腔镜胆囊切除术。使用苏格兰国家记录数据库的年中人口估计;计算1998-2015年不同年龄和性别的腹腔镜胆囊切除术年发病率。观察到的病例组合趋势采用单变量线性回归和学生t检验进行检验。结果:1998-2015年;141例小儿腹腔镜胆囊切除术。胆囊切除术的年发生率从0.10/10万增加到0.88/10万(p = 0.069)。确定了特定性别的发病率;女孩为0.00 ~ 0.90/100,000 (p = 0.098),男孩为0.20 ~ 0.86/100,000 (p = 0.28)。胆囊切除术在女孩中更为常见(63%;p = 0.04)。未发现主要并发症,定义为胆总管损伤或死亡。整体;75%的病例由咨询医生进行(n = 17名咨询医生,中位数= 5例,p)结论:我们已经证明,尽管全国病例量低(每年8例腹腔镜胆囊切除术),儿科外科医生已经能够安全地进行腹腔镜胆囊切除术,没有重大并发症。
{"title":"Introduction of paediatric laparoscopic cholecystectomy in Scotland: a national review of incidence, outcomes and training implications.","authors":"P Sekaran,&nbsp;A R Ross,&nbsp;A Rooney,&nbsp;G Duthie,&nbsp;M Clarke,&nbsp;F D Munro,&nbsp;A J Sabharwal","doi":"10.1177/0036933021995958","DOIUrl":"https://doi.org/10.1177/0036933021995958","url":null,"abstract":"<p><strong>Background: </strong>We present a national data series to determine the incidence, outcomes and training opportunities for laparoscopic cholecystectomy among children <16yrs in Scotland as performed by paediatric surgeons.</p><p><strong>Methods: </strong>A retrospective cohort study was performed reviewing laparoscopic cholecystectomy performed at the three children's hospitals in Scotland. Using the National Records Scotland Database mid-year population estimates; age and sex specific annual incidence rates of laparoscopic cholecystectomy were calculated between 1998-2015. Trends in the observed case mix were tested using univariate linear regression and students t-test.</p><p><strong>Results: </strong>Between 1998-2015; 141 paediatric laparoscopic cholecystectomies were performed. The annual rate of cholecystectomy increased from 0.10/100,000 to 0.88/100,000 (p = 0.069). Sex specific incidences were identified; 0.00-0.90/100,000 (p = 0.098) in girls and 0.20-0.86/100,000 in boys (p = 0.28). Cholecystectomy was more frequent in girls (63%; p = 0.04). No major complications, defined as common bile duct injury or mortality were identified. Overall; 75% of cases were performed by consultants (n = 17 consultants, median = 5 cases, p < 0.05) and 25% by trainees.</p><p><strong>Conclusion: </strong>We have demonstrated that despite a low national case load (8 laparoscopic cholecystectomies per year) paediatric surgeons have been able to perform laparoscopic cholecystectomy safely without major morbidity.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"66 3","pages":"148-151"},"PeriodicalIF":2.7,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/0036933021995958","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25527065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Scottish Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1